Australian Government

Federal Register of Legislation

Therapeutic Goods (Standard for Labelling of Prescription Medicines) (TGO 115) Order 2026

In force

Administered by

Department of Health, Disability and Ageing

This item is authorised by the following title:

Therapeutic Goods Act 1989

Latest version

F2026L01311

28 September 2026

Table of contents

Part 1—Preliminary
Part 2—General labelling provisions
- 8 General requirements
- 9 Machine readable codes
Part 3—Labelling requirements for primary packs, intermediate packaging
Part 4—Additional labelling requirements for certain medicines
Part 5—How information is to be expressed on the label
Part 6—Application, saving and transitional provisions
- 44 Listing active ingredients on certain medicines
- 45 TGO 91
  - Schedule 1—Substances that are required to be declared on the label
  - Schedule 2—Specified ingredient names
Part 1—Dual labelling name
Part 2—Dual labelling name permitted until 30 April 2028
- Schedule 3—Specified neuromuscular blocking agents (including their salts)
- Schedule 4—Repeals
  - Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines